Cited by 33Wound Healing and TreatmentsBiochemical effects in animalsSkin Protection and Aging

The potential of GHK as an anti-aging peptide

Open access
Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, WA, USA, Dou, Yan, Lee, Amanda, Zhu, Lida, Morton, John, Ladiges, Warren·2020·Aging Pathobiology and Therapeutics

Abstract

GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring peptide found in human serum with levels averaging 200 ng/ml at age 20 but declining to an average of 80 ng/ml by age 60. The molecule has a very high affinity for copper and forms the chelate GHK-Cu. The peptide as well as its Cu (II) chelate have anti-inflammatory and tissue remodeling properties. GHK-Cu has been shown to promote skin remodeling, wound healing and regeneration, and has prominent antioxidant and anti-inflammatory effects in in vitro and in vivo studies. In addition, preliminary observations suggest GHK can partially reverse cognitive impairment in aging mice by targeting anti-inflammatory and epigenetic pathways. The evidence as presented provides the rationale to further investigate this naturally occurring peptide in preclinical and clinical aging studies.

Integrity signals

Registry

Crossref · 10.31491/apt.2020.03.014

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

21 of 50 cited sources checked · 2 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    At low concentrations, GHK-Cu stimulates the migration of macrophages and mast cells.

    “GHK-Cu at low concentrations is a powerful attractant for capillary cells that build new blood vessels, and a powerful migration stimulant for macrophages and mast cells that remove damaged cellular debris and secrete proteins important for wound contraction and tissue healing [8–9].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [8]
    • cites [9] source

      The Introduction says GHK-Cu is a potent chemotactic agent for monocytes/macrophages and mast cells, supporting the migration claim. It does not specify that this effect occurs at low concentrations; the paper’s dose-response results concern connective-tissue accumulation, not migration. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Premisecitation

    GHK-Cu increases the expression of bFGF and VEGF in irradiated human dermal fibroblasts at a concentration of 1 nM.

    “GHK-Cu at a concentration of 1nM increases the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in irradiated human dermal fibroblasts, both of which aid blood vessel formation and blood flow into damaged tissues [4–6].”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites [4] source
    • cites [5] source

      The sections on FGF signaling and repair discuss angiogenesis and wound healing, but do not address GHK-Cu treatment. Searches for GHK-Cu, irradiated dermal fibroblasts, and the 1 nM concentration found no passage reporting the claimed increase in bFGF or VEGF expression. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [6] source
  • Premisecitation

    Copper is an important trace element in the production of collagen and elastin.

    “Since copper is an important trace element that plays a key factor in the production of collagen and elastin, GHK-Cu can be a natural supplement for copper in the connective tissue synthesis [10–11].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [10] source
    • cites [11] source

      The Results section ('GHK-Cu increases extracellular matrix deposition in wound chambers'; page unavailable) reports increased collagen in wounds treated with the copper-containing complex GHK-Cu. It does not establish that copper alone is an important trace element for collagen production, and the passages found do not address elastin production (searched: 'elastin' and 'elastin synthesis copper connective tissue'). (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • Premisecitation

    At low concentrations, GHK-Cu attracts capillary cells that form new blood vessels.

    “GHK-Cu at low concentrations is a powerful attractant for capillary cells that build new blood vessels, and a powerful migration stimulant for macrophages and mast cells that remove damaged cellular debris and secrete proteins important for wound contraction and tissue healing [8–9].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [8]
    • cites [9] source

      The Discussion describes GHK-Cu as a potent chemoattractant for endothelial cells, and the Introduction reports that it can trigger angiogenesis in vivo. The paper does not say that the attraction occurs at low concentrations; its dose results concern connective-tissue accumulation, not endothelial-cell attraction. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Premisecitation

    GHK is a naturally occurring peptide present in human serum.

    “GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring peptide originally found in human serum and shown to stimulate growth in hepatoma cells [1].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [1] source

      The References (page not specified) identify GHK as a human-plasma tripeptide, and Figure 8 (p. 938) shows that GHK can be released from SPARC by digestion. Our copy does not establish that GHK is present in human serum specifically; plasma and serum are not interchangeable for this claim. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
  • May combine two claims. 9
  • May combine two claims.

    Premisecitation

    In a bleomycin-induced fibrosis mouse model, GHK reduces inflammatory cell infiltration and interstitial thickness and lowers TNF-α and IL-6 expression.

    “In a bleomycin-induced fibrosis mouse model, treatment with GHK showed reduced inflammatory cell infiltration and interstitial thickness with reduced TNF-α and IL-6 expression, suggesting GHK as a potential treatment for pulmonary fibrosis [21].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [21] source

      The lung-damage Results section (page unavailable) reports that GHK-Cu mitigated lung pathology, including immune-cell infiltration and alveolar wall thickening. The cytokine Results section reports lower TNF-α and IL-6 in treated mice. But this was an LPS-induced acute lung injury model, not a bleomycin-induced fibrosis model, so the cited paper does not establish GHK as a potential treatment for pulmonary fibrosis. (LLM, conf=0.89)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Interpretationcitation

    The ability of GHK and its Cu chelate to promote skin remodeling, wound healing and regeneration, and their antioxidant and anti-inflammatory effects, will help enhance healthy aging.

    “The ability of GHK and its Cu chelate to promote skin remodeling, wound healing and regeneration, and its prominent antioxidant and anti-inflammatory effects are qualities that will help enhance healthy aging [28–31].”
    Quote in the paperSubstantial claim3 of 4 sources checked
    • cites [28] source

      The Conclusion and Future Perspectives (page unavailable) discusses healthy aging and suggests that therapeutic modulation of reactive oxygen species is relevant to aging. It does not discuss GHK or its copper chelate, so it cannot support the attributed claims about their skin-remodeling, wound-healing, regenerative, antioxidant, or anti-inflammatory effects. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [29] source

      The Introduction discusses senescence, tissue deterioration, and aging, while the matching References passages concern regeneration and inflammation in other contexts. Searches for GHK, its copper chelate, and the claimed skin-remodeling, wound-healing, antioxidant, and anti-inflammatory effects found no passage attributing those effects to GHK or linking them to healthy aging. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [30] source

      Section 2.1 discusses antioxidant enzymes and aging, and Section 6.2 discusses exercise-related antioxidant responses. Neither addresses GHK, its copper chelate, or their effects on skin remodeling, wound healing, and regeneration; searches for GHK and the copper peptide found no pertinent passage in our copy. (LLM, conf=0.74)

      Experimental — accuracy not yet measured
    • cites [31] source
  • May combine two claims.

    Premisecitation

    GHK quenches hydroxyl and peroxyl radicals by ESR spectroscopy, and its hydroxyl radical quenching is stronger than that of glutathione.

    “Moreover, GHK has been shown to be a quencher for hydroxyl and peroxyl radicals by ESR spectroscopy, with its ability to quench hydroxyl radicals much stronger than glutathione (GSH), making it a strong endogenous antioxidant [20].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [20] source

      The Introduction describes GHK as a normal component of human plasma, and the Discussion reports anti-inflammatory and anti-fibrotic effects. Neither passage addresses hydroxyl or peroxyl radical quenching, ESR spectroscopy, or a comparison with glutathione; searches for those terms and antioxidant activity found no supporting passage in our copy. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    Immunohistochemistry of brain tissue from GHK-treated mice shows decreased inflammation and increased histone deacetylase 2 labeling.

    “Immunohistochemistry of brain tissues from mice treated with GHK showed evidence of decreased inflammation and increased labeling of histone deacetylase 2, suggesting that in addition to an anti-inflammatory effect, GHK may be triggering an epigenetic pathway in the amelioration of cognitive impairment in aging mice.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    GHK is released from the protein SPARC when the extracellular matrix is degraded, and this release supports tissue remodeling by raising angiogenesis.

    “The peptide is cleaved and released from its parent protein SPARC during the degradation of extracellular matrix, to aid in tissue remodeling by increasing levels of angiogenesis [2].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [2] source
  • May combine two claims.

    Premisecitation

    GHK-Cu increases HUVEC proliferation by stimulating VEGF and FGF-2 expression, which promotes angiogenesis.

    “It also increases HUVECs proliferation by stimulating VEGF and FGF-2 expressions, promoting angiogenesis that aids in wound healing [7].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [7]

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    GHK-Cu pretreatment increases SOD activity and total GSH in RAW 264.7 macrophage cells.

    “Pretreatment of RAW 264.7 macrophage cells with GHK-Cu has been shown to significantly decrease ROS levels induced by lipopolysaccharide (LPS), increase levels of SOD activities and total GSH, and decrease levels of TNF-α and IL-6 production through the suppression of NF-κB p65 and p38 MAPK signaling [22].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [22] source
  • May combine two claims.

    Premisecitation

    In an LPS-induced acute lung injury mouse model, GHK-Cu suppresses TNF-α and IL-6 expression and decreases NF-κB p65 and p38 MAPK signaling.

    “In the LPS-induced acute lung injury mouse model, treatment of GHK-Cu also significantly suppressed TNF-α and IL-6 expression with a significant decrease of both NF-κB p65 and p38 MAPK signaling, suggesting that GHK-Cu is useful for the development of novel anti-inflammatory therapies [22].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [22] source
  • May combine two claims.

    Premisecitation

    Clinical studies show that GHK-Cu in skin cream leads to faster healing and better skin condition.

    “In addition to wound healing studies in mice, clinical studies have been done on the effect of GHK-Cu on skin regeneration, which show a more rapid healing process and better skin conditions with GHK-Cu in the skin cream [3, 17].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [3] source
    • cites [17] source
9 of 9
  • The paper relies on this without support.

    GHK has a very high affinity for copper(II) and forms the chelate GHK-Cu.

    “The molecule has a very high affinity for copper (II) and forms the chelate GHK-Cu.”
  • The paper relies on this without support.

    Plasma GHK level is about 200 ng/ml at age 20 and declines to 80 ng/ml by age 60.

    “The plasma level of GHK is about 200 ng/ml at age 20 but declines to 80 ng/ml by age 60.”
  • The paper relies on this without support.

    No studies have linked low serum GHK levels with specific aging processes or age-related disease.

    “However, no studies have yet been reported linking low serum GHK levels with specific aging processes or age-related disease.”
  • The paper relies on this without support.

    GHK is absorbed at high efficiency across the blood brain barrier into brains of rodents and nonhuman primates when delivered parenterally.

    “Since GHK is absorbed at a high efficiency across the blood brain barrier into the brains of rodents and nonhuman primates when delivered parenterally, testing the effects of the peptide on neurological function is warranted.”
4 of 4

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Department of Comparative Medicine, S. O. M., Dou, Y., Lee, A., Zhu, L., Morton, J., & Ladiges, W.
Affiliations
University of Washington (US)
Corresponding author
Ladiges, Warren
Venue
Aging Pathobiology and Therapeutics
Published
2020-03-27
Volume
2
Issue
1
Pages
58-61
ISSN
2690-1803 (ISSN-L)
OpenAlex
W3013536180
Cited by
33
References
33
Citations by year
2026: 10 · 2025: 11 · 2024: 6 · 2023: 4 · 2022: 1 · 2020: 1
FWCI
0.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Aging Pathobiology and Therapeutics (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (R01AG067193, AG057381, R56AG058543, R01AG057381)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Health Sciences › Medicine › Physiology › Biochemical effects in animals
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
Keywords
copper chelates, anti-aging, dermal remodeling, wound healing, tissue regeneration, antioxidant activity, anti-inflammatory activity, cognitive impairment, epigenetic mechanisms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read under definition version 3 (extract-v3) on 2026-09-28.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review